Abstract

Menopause is an important event in a woman’s life associated with hormonal changes that play a substantial role in the functioning of her body. A decline in the level of estrogens contributes to depressive symptoms and mood disorders during this period. The severity of depressive symptoms experienced by middle-aged women depends on many factors, including sociodemographic data (e.g., menopause, employment status, and marital status) and genetic variables (MAO-A and 5-HTT gene polymorphisms). In order to assess their influence on the development of depression in females, we analyzed 1453 healthy Polish women in different stages of menopause. Based on the results, we found that the l/l + l/s inheritance model for the 5-HTT gene polymorphism was more common in women without and with moderate depressive symptoms according to the Beck Depression Inventory (BDI), while the l/s model was more often observed in women with mild depression. Moreover, the overdominant 3/3 + 4/4 genotype of the MAO-A gene polymorphism was more often found in respondents without depressive symptoms, while women with depressive symptoms had more often the overdominant 3/4 genotype.

Highlights

  • IntroductionAccording to the World Health Organization (WHO), natural menopause is the “permanent cessation of menstruation resulting from the loss of ovarian follicular activity” [1]

  • We found that the severity of depressive symptoms according to the Beck Depression Inventory (BDI) was significantly related to the frequency of the genotypes of the 44-bp VNTR polymorphism in the 5-HTT gene promoter region (p < 0.05)

  • The analysis demonstrated statistically significant relationships between the frequency of the genotypes of the 30-bp VNTR polymorphism in the monoamine oxidase A (MAO-A) gene promoter region and the severity of depression according to the BDI (p < 0.05)

Read more

Summary

Introduction

According to the World Health Organization (WHO), natural menopause is the “permanent cessation of menstruation resulting from the loss of ovarian follicular activity” [1]. It has been divided into three stages, namely, premenopause—defined as the entire period of reproductive life before menopause; perimenopause—the immediate time before menopause with the symptoms of the approaching menopause (when the endocrine, biological, and clinical features of the approaching menopause begin) and the first year after menopause; and postmenopause—the time after the last menstruation (natural or artificial) [2,3]. Estrogen, which is a mood modulator, plays a major role in depressive disorders in women, and its deficiency has a negative impact on their well-being [6]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call